Diabetic nephropathy, inflammation, hyaluronan and interstitial fibrosis

Histology and Histopathology

Volumn 23, Issue 6, 2008, Pages 731-739

  Lewis, Aled ^a   Steadman, Robert ^a   Manley, Paul ^a   Craig, Kathrine ^a   de la Motte, Carol ^b   Hascall, Vincent ^b   Phillips, Aled O ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Diabetic nephropathy; Hyaluronan; Interstitial fibrosis; Macrophages

Indexed keywords

BIOLOGICAL MARKER; CD68 ANTIGEN, HUMAN; DIFFERENTIATION ANTIGEN; HYALURONIC ACID; LEUKOCYTE ANTIGEN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; DIABETIC NEPHROPATHY; DISEASE COURSE; ENZYME IMMUNOASSAY; EXTRACELLULAR MATRIX; FEMALE; FIBROSIS; GLOMERULUS FILTRATION RATE; HUMAN; IMMUNOLOGY; INTERSTITIAL NEPHRITIS; MACROPHAGE; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY;

ADULT; AGED; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; BIOLOGICAL MARKERS; DIABETIC NEPHROPATHIES; DISEASE PROGRESSION; EXTRACELLULAR MATRIX; FEMALE; FIBROSIS; GLOMERULAR FILTRATION RATE; HUMANS; HYALURONIC ACID; IMMUNOENZYME TECHNIQUES; MACROPHAGES; MALE; MIDDLE AGED; NEPHRITIS, INTERSTITIAL;

EID: 42149155557     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Beck-Schimmer B., Oertli B., Pasch T. and Wüthrich R.P. (1998). Hyaluronan induces monocyte chemoattractant protein-1 expression in renal tubular epithelial cells. J. Am. Soc. Nephrol. 9, 2283-2290.
2. Bohle A., Wehrmann M., Bogenschutz O., Batz C. and Muller G.A. (1991). The pathogenesis of chronic renal failure in diabetic nephropathy. Pathol. Res. Pract. 187, 251-259.
3. Chantrel F., Enache I., Bouiller M., Kolb I., Kunz K., Petitjean P., Moulin B. and Hannedouche T. (1999). Abysmal prognosis of patients with type 2 diabetes entering dialysis. Nephrol. Dial. Transplant. 14, 129-36.
4. Chow F., Ozols E., Nikolic-Paterson D.J., Atkins R.C. and Tesch G.H. (2004). Macrophages in mouse type 2 diabetic nephropathy: Correlation with diabetic state and progressive renal injury. Kidney Int. 65 116-28.
5. Chow F.Y., Nikolic-Paterson D.J., Ozols E., Atkins R.C. and Tesch G.H. (2005). Intercellular adhesion molecule-1 deficiency is protective against nephropathy in type 2 diabetic db/db mice. J. Am. Soc. Nephrol. 16, 1711-1722.
6. Furuta T., Saito T., Ootaka T., Soma J., Obara K., Keishi A. and Yohinaga K. (1993). The role of macrophages in diabetic glomerulosclerosis. Am. J. Kid. Dis. 21 480-485.
7. Ghavamian M., Gutch C.F., Kopp K.F. and Kolff W.J. (1972). The sad truth about hemodialysis in diabetic nephropathy. JAMA. 222, 1386-1389.
8. Hansell P, Göransson V., Odlind C., Gerdin B. and Hällgren R. (2000). Hyaluronan content in the kidney in different states of body hydration. Kidney Int. 58, 2061-2068.
9. Ito T., Williams J.D., Fraser D.J. and Phillips A.O. (2004a). Hyaluronan attenuates TGF-ß1 mediated signalling in renal proximal tubular epithelial cells. Am. J. Pathol. 164, 1979-1988.
10. Ito T., Williams J.D., Fraser D.J. and Phillips A.O. (2004b). Hyaluronan regulates TGF-ß1 receptor compartmentalisation. J. Biol. Chem. 279, 25326-25332.
11. Janssen U., Thomas G., Glant T. and Phillips A.O. (2001). Regulation of inter-alpha-trypsin inhibitor (IαI) and tumour necrosis factor-stimulated gene 6 (TSG-6) expression in human renal proximal tubular epithelial cells. Kidney Int. 60 126-136.
12. Jones S.G., Jones S. and Phillips A.O. (2001). Regulation of renal proximal tubular epithelial cell hyaluronan generation: Implications for diabetic nephropathy. Kidney Int. 59, 1739-1749.
13. Lane P.H., Steffes M.W., Fioretto P. and Mauer S.M. (1993). Renal interstitial expansion in insulin-dependant diabetes mellitus. Kidney Int. 43, 661-667.
14. Laurent T.C. and Fraser R.E. (1992). Hyaluronan. FASEB J. 6, 2397-2404.
15. Lavaud S., Michel O., Sassy-Prigent C., Heudes D., Bariety J., Chevalier J., Belair M.F. and Mandet C. (1996). Early influx of glomerular macrophages precedes glomerulosclerosis in the Obese Zucker Rat model. J. Am. Soc. Nephrol. 7 2604-2615.
16. Lewington A.J.P., Padanilam B.J., Martin D.R. and Hammeramn M.R. (2000). Expression of CD44 in kidney after acute ischemic injury in rats. Am. J. Physiol. 278 R247-R254.
17. Mahadevan P., Larkins R.G., Fraser J.R.E., Fosang A.J. and Dunlop M.E. (1995). Increased hyaluronan production in the glomeruli from diabetic rats: link between glucose induced prostaglandin production and reduced sulphated proteoglycans. Diabetologia 38, 298-305.
18. Marcelli D., Spotti D., Conte F., Limido A., Lonati F., Malberti F. and Locatelli F. (1995). Prognosis of diabetic patients on dialysis: analysis of Lombardy registry data. Nephrol. Dial. Transplant. 10 1895-1900.
19. National Kidney Foundation (2002). K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am. J. Kid. Dis. 39 S1-266.
20. Oertli B., Beck-Schimmer B., Fan X. and Wüthrich R.P. (1998). Mechanisms of hyaluronan-induced up-regulation of ICAM-1 and VCAM-1 expression by murine kidney tubular epithelial cells: Hyaluronan triggers cell adhesion molecule expression through a mechanism involving activation of nuclear factor-kB activating protein-1. J. Immunol. 161 3431-3437.
21. Okada S., Shikata K., Matsuda M., Ogawa D., Usui H., Kido Y., Nagase R., Wada J., Shikata Y. and Makino H. (2003). Intercellular adhesion molecule-1-deficient mice are resistant against renal injury after induction of diabetes. Diabetes 52 2586-93.
22. Sassy-Pringent C., Heudes D., Mandet C., Belair M.F., Michel O., Perdereau B., Bariety J. and Bruneval P. (2000). Early glomerular macrophage recruitment in streptozotocin induced diabetic rats. Diabetes 49, 466-475.
23. Selbi W., Day A.J., Rugg M.S., Fülöp C., de la Motte C.A., Bowen T., Hascall V.C. and Phillips A.O. (2006a). Over-expression of hyaluronan synthase 2 alters hyaluronan distribution and function in proximal tubular epithelial cells. J. Am. Soc. Nephrol. 17 1553-1567.
24. Selbi W., de la Motte C.A., Hascall V.C., Day A.J., Bowen T. and Phillips A.O. (2006b). Characterization of hyaluronan cable structure and function in renal proximal tubular epithelial cells. Kidney Int. 70 1287-1295.
25. Selbi W.D., De La Motte C.A., Hascall V.C. and Phillips A.O. (2004). BMP-7 modulates HA mediated proximal tubular cell-monocyte interaction. J. Am. Soc. Nephrol. 15 1199-1211.
26. Shih W., Hines W.H. and Neilson E.G. (1988). Effects of cyclosporin A on the development of immune-mediated interstitial nephritis. Kidney Int. 33 1113-1118.
27. Sibalic V., Fan X., Loffing J. and Würthrich R.P. (1997). Upregulated renal tubular CD44, hyaluronan, and osteopontin in kdkd mice with interstitial nephritis. Nephrol. Dial. Transplant. 12 1344-1353.
28. UK Renal Registry B UK (2005). UK Renal Registry Report.
29. Wells A., Larsson E., Hanas E., Laurent T., Hallgren R. and Tufvesson G. (1993). Increased hyaluronan in acutely rejecting human kidney grafts. Transplantation 55, 1346-1349.
30. Wells A.F., Larsson E., Tengblad A., Fellstrom B., Tufvesson G., Klareskog L. and Laurent T.C. (1990). The localisation of hyaluronan in normal and rejected human kidneys. Transplantation 50, 240-243.
31. Yonemoto S., Machiguchi T., Nomura K., Minakata T., Nanno M. and Yoshida H. (2006). Correlations of tissue macrophages and cytoskeletal protein expression with renal fibrosis in patients with diabetes mellitus. Clin. Exp. Nephrol. 10, 186-192.
32. Young B.A., Johnson R.J., Alpers C.E., Eng C.E., Gordon K., Floege J. and Couser W. (1995). Cellular events in the evolution of experimental diabetic nephropathy. Kidney Int. 47. 935-944.
33. Zhang X.L., Selbi W.D., De La Motte C.A., Hascall V.C. and Phillips A.O. (2004). Renal proximal tubular epithelial cells Transforming Growth Factor ß1 generation and monocyte binding. Am. J. Pathol. 165, 763-773.
34. Zhang X.L., Selbi W.D., De La Motte C.A., Hascall V.C. and Phillips A.O. (2005). BMP-7 inhibits monocyte stimulated TGF-ß1 generation in renal proximal tubular epithelial cells. J. Am. Soc. Nephrol. 1, 79-89.
35. Zhuo L., Hascall V.C. and Kimata K. (2004). Inter-alpha-trypsin inhibitor, a covalent protein-glycosaminoglycan-protein complex. J. Biol. Chem. 279, 38079-38082.